ADVERTISEMENT
ADVERTISEMENT

cancer

Scientist Who Received Millions From NIH Leaves Alabama Posts
Ivan Oransky, Retraction Watch | May 24, 2018 | 2 min read
An investigation finds 20 papers by Santosh Katiyar, who studied alternative treatments for cancer, include image manipulation.
Prevalent Form of Childhood Leukemia May Be Preventable
Sukanya Charuchandra | May 22, 2018 | 2 min read
Early exposure to common microbes could stop leukemia from manifesting in children.
Immunotherapy More Effective in Men: Study
Kerry Grens | May 18, 2018 | 2 min read
Women with metastatic cancer who were treated with a checkpoint inhibitor had a smaller benefit than did men.
Image of the Day: Cancer Spheroid
The Scientist Staff | May 15, 2018 | 1 min read
3-D balls of cells can be used to screen for potential cancer drugs.
Genetic Screen Predicts T-Cell Lymphoma Aggression
Kerry Grens | May 9, 2018 | 2 min read
Sequencing of a single gene can spot patients with a dangerous form of mycosis fungoides better than other prognostic tests.  
Big Data in 3 Dimensions
Jim Daley | May 1, 2018 | 2 min read
Viewing oncogenic mutations in 3-D showed that they cluster together on folded proteins.
Caught on Camera
The Scientist | May 1, 2018 | 1 min read
Selected rare-disease Images of the Day from the-scientist.com
Salk Institute Suspends Cancer Scientist Inder Verma
Ashley Yeager | Apr 23, 2018 | 2 min read
The prominent researcher has been put on administrative leave pending an investigation into unspecified allegations.
Mitochondrial DNA Plays a Role in Metastasis
Kerry Grens | Apr 18, 2018 | 2 min read
Experiments in mice show that mitochondria, both within the tumor and beyond, can make the difference between promoting or inhibiting cancer spread.
How Kidney Cancer Evolves
Jim Daley | Apr 18, 2018 | 2 min read
Renal cell carcinoma tumors have three different evolutionary fates, each associated with specific clinical outcomes.
Immune Therapy Improves Lung Cancer Patients’ Survival
Jim Daley | Apr 16, 2018 | 2 min read
Pembrolizumab combined with chemotherapy nearly doubles survival rates and shrinks tumors in some individuals.
Antibody Combo Expands Response to Checkpoint Inhibitor in Mice
Kerry Grens | Apr 16, 2018 | 2 min read
Genetic analyses uncover cellular hallmarks of bladder cancer tumors that don’t respond, but interfering with one of those characteristics in a mouse model causes tumors to shrink.  
Birth Defects Linked to Increased Risk of Childhood Cancer
Jim Daley | Apr 15, 2018 | 2 min read
Certain non-chromosomal defects are strongly associated with specific childhood cancers.
Wound-Healing in Mice Triggers Growth of Dormant Tumors
Jim Daley | Apr 12, 2018 | 2 min read
Treating mice with anti-inflammatory drugs following surgery reduced the size of tumors.
Image of the Day: Tumor Organoids
The Scientist and The Scientist Staff | Apr 11, 2018 | 1 min read
Miniature versions of bladder cancers could help physicians identify personalized treatment options for patients.
Human Cancer Drugs May Be Effective in Tasmanian Devils
Shawna Williams | Apr 9, 2018 | 2 min read
A new study reveals similarities between the transmissible cancers that infect the endangered marsupials, and hints at ways to treat them.
Hundreds of Inherited Gene Variants Contribute to Cancer
Abby Olena, PhD | Apr 5, 2018 | 3 min read
In the largest study of its kind to date, researchers find more than 850 rare, heritable genetic alterations that can predispose humans to cancer.
OSU Professor Falsified Data on Eight Papers, Resigns
Catherine Offord | Apr 2, 2018 | 2 min read
Ching-Shih Chen’s research involved anticancer therapeutics that were being tested in clinical trials.
A Radical Intervention, 1894
Catherine Offord | Apr 1, 2018 | 3 min read
William Halsted’s approach to mastectomy took the medical world by storm at the turn of the last century.
A Neuroscientist’s Journey Through Madness
Barbara Lipska with Elaine McArdle | Apr 1, 2018 | 3 min read
After I was diagnosed with brain cancer and started to lose my mental health, the importance of my job came into clear focus.
ADVERTISEMENT